Daniela Rizzi

634 total citations
15 papers, 542 citations indexed

About

Daniela Rizzi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Daniela Rizzi has authored 15 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Daniela Rizzi's work include Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (14 papers) and Pain Mechanisms and Treatments (5 papers). Daniela Rizzi is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (14 papers) and Pain Mechanisms and Treatments (5 papers). Daniela Rizzi collaborates with scholars based in Italy, United Kingdom and Switzerland. Daniela Rizzi's co-authors include Remo Guerrini, D. Regoli, Severo Salvadori, Anna Rizzi, Girolamo Calò, Raffaella Bigoni, Giuliano Marzola, David G. Lambert, Michele Morari and G. Calo' and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Daniela Rizzi

15 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Rizzi Italy 12 506 485 148 82 22 15 542
Jennifer P. Ryan‐Moro United States 7 451 0.9× 370 0.8× 226 1.5× 58 0.7× 34 1.5× 8 476
Mitsuru Miyaji Japan 6 376 0.7× 364 0.8× 220 1.5× 46 0.6× 29 1.3× 7 466
Horace H. Loh United States 6 393 0.8× 334 0.7× 158 1.1× 60 0.7× 24 1.1× 9 439
Ilona Berzétei Hungary 11 280 0.6× 290 0.6× 67 0.5× 20 0.2× 8 0.4× 17 372
Jean Cros France 11 396 0.8× 305 0.6× 168 1.1× 24 0.3× 46 2.1× 15 455
Yoshikazu Katao Japan 7 494 1.0× 436 0.9× 154 1.0× 18 0.2× 12 0.5× 7 533
Larry S. Birkemo United States 8 319 0.6× 297 0.6× 35 0.2× 71 0.9× 29 1.3× 10 459
JC Hunter United Kingdom 8 294 0.6× 272 0.6× 98 0.7× 11 0.1× 60 2.7× 9 424
Bernard Labeeuw France 5 282 0.6× 238 0.5× 36 0.2× 53 0.6× 4 0.2× 6 348
Wieslaw Kazmierski United States 7 262 0.5× 289 0.6× 94 0.6× 9 0.1× 19 0.9× 14 389

Countries citing papers authored by Daniela Rizzi

Since Specialization
Citations

This map shows the geographic impact of Daniela Rizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Rizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Rizzi more than expected).

Fields of papers citing papers by Daniela Rizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Rizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Rizzi. The network helps show where Daniela Rizzi may publish in the future.

Co-authorship network of co-authors of Daniela Rizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Rizzi. A scholar is included among the top collaborators of Daniela Rizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Rizzi. Daniela Rizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Rizzi, Anna, Remo Guerrini, Timothy Barnes, et al.. (2005). [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1114–1123. 28 indexed citations
2.
Guerrini, Remo, Girolamo Calò, David G. Lambert, et al.. (2005). N- and C-Terminal Modifications of Nociceptin/Orphanin FQ Generate Highly Potent NOP Receptor Ligands. Journal of Medicinal Chemistry. 48(5). 1421–1427. 22 indexed citations
3.
Guerrini, Remo, Girolamo Calò, Claudio Trapella, et al.. (2004). Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity. Journal of Peptide Research. 63(6). 477–484. 11 indexed citations
4.
Guerrini, Remo, Daniela Rizzi, Roberto Tomatis, et al.. (2003). Nociceptin/Orphanin FQ(1–13)NH2 analogues modified in the Phe1-Gly2 peptide bond. Bioorganic & Medicinal Chemistry Letters. 13(3). 365–368. 12 indexed citations
5.
Rizzi, Daniela, Anna Rizzi, Raffaella Bigoni, et al.. (2002). [Arg14,Lys15]Nociceptin, a Highly Potent Agonist of the Nociceptin/Orphanin FQ Receptor: in Vitro and in Vivo Studies. Journal of Pharmacology and Experimental Therapeutics. 300(1). 57–63. 45 indexed citations
6.
Rizzi, Daniela, et al.. (2002). The Effect of Guanethidine and Local Anesthetics on the Electrically Stimulated Mouse Vas Deferens. Anesthesia & Analgesia. 95(5). 1339–1343. 1 indexed citations
7.
Bigoni, Raffaella, Daniela Rizzi, Anna Rizzi, et al.. (2002). Pharmacological characterisation of [(pX)Phe 4 ]nociceptin(1-13)amide analogues. Naunyn-Schmiedeberg s Archives of Pharmacology. 365(6). 442–449. 25 indexed citations
8.
Rizzi, Anna, Daniela Rizzi, Giuliano Marzola, et al.. (2002). Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice. British Journal of Pharmacology. 137(3). 369–374. 39 indexed citations
9.
Balboni, Gianfranco, Remo Guerrini, Severo Salvadori, et al.. (2002). Evaluation of the Dmt−Tic Pharmacophore:  Conversion of a Potent δ-Opioid Receptor Antagonist into a Potent δ Agonist and Ligands with Mixed Properties. Journal of Medicinal Chemistry. 45(3). 713–720. 77 indexed citations
10.
Calò, Girolamo, Anna Rizzi, Daniela Rizzi, et al.. (2002). [Nphe1,Arg14,Lys15]Nociceptin‐NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor. British Journal of Pharmacology. 136(2). 303–311. 148 indexed citations
11.
Rizzi, Daniela, Raffaella Bigoni, Anna Rizzi, et al.. (2001). Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues. Naunyn-Schmiedeberg s Archives of Pharmacology. 363(5). 551–555. 37 indexed citations
12.
Guerrini, Remo, Girolamo Calò, Raffaella Bigoni, et al.. (2001). Structure−Activity Studies of the Phe4 Residue of Nociceptin(1−13)-NH2:  Identification of Highly Potent Agonists of the Nociceptin/Orphanin FQ Receptor. Journal of Medicinal Chemistry. 44(23). 3956–3964. 40 indexed citations
13.
Guerrini, Remo, Severo Salvadori, G. Calo', et al.. (2001). Structure–activity relationship of [Nphe1]‐NC‐(1‐13)‐NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist. Journal of Peptide Research. 57(3). 215–222. 13 indexed citations
14.
Bigoni, Raffaella, A. Rizzi, Daniela Rizzi, et al.. (2000). In vitro pharmacological profile of peptide III-BTD. Life Sciences. 68(2). 233–239. 11 indexed citations
15.
Guerrini, Remo, G. Calo', Anna Rizzi, et al.. (2000). Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A. Peptides. 21(7). 923–933. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer P. Ryan‐Moro Breakdown of academic impact, for papers by Mitsuru Miyaji Breakdown of academic impact, for papers by Horace H. Loh Breakdown of academic impact, for papers by Ilona Berzétei Breakdown of academic impact, for papers by Jean Cros Breakdown of academic impact, for papers by Yoshikazu Katao Breakdown of academic impact, for papers by Larry S. Birkemo Breakdown of academic impact, for papers by JC Hunter Breakdown of academic impact, for papers by Bernard Labeeuw Breakdown of academic impact, for papers by Wieslaw Kazmierski
Rankless by CCL
2026